Peter Schirmacher

机构：Heidelberg University, University Hospital Heidelberg, Heidelberg University · ORCID：0000-0002-0950-3339

发表论文 1414 篇 · 总被引 64430 次 · h-index 109

代表论文

• Regulation of laboratory-developed tests and in-house in vitro diagnostic medical devices in the United States and the European Union—a comparative overview (2025 · ESMO Open · 被引 12)
• Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab – a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial) (2025 · BMJ Open · 被引 11)
• Germany’s national genomDE strategy (2025 · Nature Medicine · 被引 8)
• Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy (2026 · Nature Communications)
• Longitudinal transcriptomic profiling of paired early and metastatic EGFR-mutant lung adenocarcinomas reveals molecular programs associated with disease progression (2026 · Lung Cancer)
• P4.890: Clinical and microbiological risk factors associated with histopathological fungal infection in liver transplant explants: A retrospective cohort analysis. (2026 · Transplantation)